The major players in the veterinary medicine market are Zoetis, Inc., Merck & Co., Inc. (Intervet International B.V.), Elanco Animal Health, Dechra Pharmaceuticals PLC, Ceva Sante Animale, Virbac., ...

Ceva-Waves Bluetooth 5.4 Low Energy IP is a comprehensive and flexible solution for integration into SoCs/ASSPs. The Ceva-Waves BLE hardware baseband controller core, in charge of packet ...

ingapore's deputy prime minister said the city-state is negotiating concessions for pharmaceutical exports to the United States after a call with US Commerce Secretary Howard Lutnick. Gan Kim Yong ...

Niche electronics company Ceva (NASDAQ: CEVA) has been an outperformer on the stock exchange of late, according to data compiled by S&P Global Market Intelligence. On Tuesday the company announced ...

This covers a product supporting advanced, next-generation vehicle assistance systems. Ceva is in the business of developing and licensing processing devices and software, and has lately attracted ...

Ironwood Pharmaceuticals (Nasdaq: IRWD) is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases.

LONDON, April 25 (Reuters) - A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on ...

The Trump administration's Section 232 investigation into pharmaceutical imports could lead to tariffs, impacting drug prices and availability. Generic drug makers, with slim profit margins ...

BOSTON - X4 Pharmaceuticals (NASDAQ:XFOR), a biopharmaceutical company focusing on rare immune diseases, will implement a one-for-thirty reverse stock split of its common stock, the firm announced ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

With a market cap of $122.6 billion, Vertex Pharmaceuticals Incorporated (VRTX) operates as a global biotechnology company that develops and commercializes therapies for treating cystic fibrosis (CF).